Primecap Management Portfolio holdings
AUM
$126B
1-Year Return
17.42%
This Quarter Return
+22.85%
1 Year Return
+17.42%
3 Year Return
+102.42%
5 Year Return
+196.08%
10 Year Return
+554.06%
AUM
$117B
AUM Growth
+$14.6B
(+14%)
Cap. Flow
-$5.63B
Cap. Flow
% of AUM
-4.83%
Top 10 Holdings %
Top 10 Hldgs %
33.15%
Holding
314
New
18
Increased
56
Reduced
195
Closed
8
Top Buys
| 1 |
ASML
ASML
|
$460M |
| 2 |
T-Mobile US
TMUS
|
$256M |
| 3 |
Carrier Global
CARR
|
$106M |
| 4 |
Baidu
BIDU
|
$87.1M |
| 5 |
Otis Worldwide
OTIS
|
$85.6M |
Top Sells
| 1 |
Adobe
ADBE
|
$651M |
| 2 |
Eli Lilly
LLY
|
$379M |
| 3 |
Microsoft
MSFT
|
$367M |
| 4 |
DFS
Discover Financial Services
DFS
|
$256M |
| 5 |
Tesla
TSLA
|
$245M |
Sector Composition
| 1 | Technology | 32.99% |
| 2 | Healthcare | 30.69% |
| 3 | Industrials | 10.56% |
| 4 | Consumer Discretionary | 9.5% |
| 5 | Financials | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Honeywell
HON
$136B
| $36.2M | 0.03% |
250,630
-768,840
| -75% | -$111M |
|
177
Cerence
CRNC
$399M
| $35.9M | 0.03% |
878,405
-6,787
| -0.8% | -$277K |
|
|
NUVA
178
DELISTED
NuVasive, Inc.
NUVA
| $34.9M | 0.03% |
627,600
-55,300
| -8% | -$3.08M |
|
|
ARNA
179
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $34.9M | 0.03% |
554,570
-25,430
| -4% | -$1.6M |
|
180
Las Vegas Sands
LVS
$36.9B
| $34.7M | 0.03% |
762,800
-14,900
| -2% | -$679K |
|
181
Ryanair
RYAAY
$32.1B
| $33.5M | 0.03% |
1,262,750
-14,750
| -1% | -$391K |
|
182
Axon Enterprise
AXON
$57.2B
| $33.5M | 0.03% |
341,000
-51,000
| -13% | -$5M |
|
183
Amicus Therapeutics
FOLD
$2.46B
| $32.1M | 0.03% |
2,130,000
-131,000
| -6% | -$1.98M |
|
184
Zentalis Pharmaceuticals
ZNTL
$126M
| $31.7M | 0.03% |
+659,950
| New | +$31.7M |
|
|
NBL
185
DELISTED
Noble Energy, Inc.
NBL
| $31M | 0.03% |
3,462,647
+32,000
| +0.9% | +$287K |
|
|
SWN
186
DELISTED
Southwestern Energy Company
SWN
| $30.7M | 0.03% |
12,001,125
-348,300
| -3% | -$892K |
|
187
Pentair
PNR
$18.1B
| $30.5M | 0.03% |
801,800
-4,110
| -0.5% | -$156K |
|
|
TPTX
188
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $29.4M | 0.03% |
+455,000
| New | +$29.4M |
|
189
VF Corp
VFC
$5.86B
| $28.7M | 0.02% |
471,700
-43,300
| -8% | -$2.64M |
|
190
IMAX
IMAX
$1.6B
| $28.5M | 0.02% |
2,543,200
-11,100
| -0.4% | -$124K |
|
191
NN Inc
NNBR
$125M
| $28.4M | 0.02% |
5,987,700
-227,600
| -4% | -$1.08M |
|
192
McDonald's
MCD
$224B
| $28M | 0.02% |
152,000
| – | – |
|
|
PRSP
193
DELISTED
Perspecta Inc. Common Stock
PRSP
| $28M | 0.02% |
1,204,721
-9,100
| -0.7% | -$211K |
|
194
Norfolk Southern
NSC
$62.3B
| $27.8M | 0.02% |
158,100
-44,200
| -22% | -$7.76M |
|
195
Altria Group
MO
$112B
| $27.6M | 0.02% |
702,424
-60,600
| -8% | -$2.38M |
|
|
PFNX
196
DELISTED
Pfenex Inc.
PFNX
| $27.1M | 0.02% |
3,244,100
-19,700
| -0.6% | -$164K |
|
197
Dell
DELL
$84.4B
| $26.2M | 0.02% |
941,265
-2,456
| -0.3% | -$68.4K |
|
198
Western Digital
WDC
$31.9B
| $26.1M | 0.02% |
783,093
+138,611
| +22% | +$4.63M |
|
199
Standard BioTools
LAB
$497M
| $24.1M | 0.02% |
6,003,443
-174,600
| -3% | -$700K |
|
200
GSK
GSK
$81.6B
| $22.8M | 0.02% |
447,440
| – | – |
|